Back to Results
First PageMeta Content
Medicine / AstraZeneca / Influenza A virus subtype H5N1 / Epidemiology / Influenza vaccines / Flu pandemic vaccine / FluMist / Center for Biologics Evaluation and Research / MedImmune / Influenza / Vaccination / Vaccines


DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike
Add to Reading List

Open Document

File Size: 244,82 KB

Share Result on Facebook

City

Québec / /

Company

T/N / ID Biomedical Corporation / GlaxoSmithKline Biologicals / CBER / Cox / VE / Glaxosmithkline plc / /

Country

Canada / /

/

Event

FDA Phase / Conference Call / /

IndustryTerm

investigational product / /

MedicalCondition

Influenza-like illness / flu / GSK Biologicals’ quadrivalent influenza / B disease / influenza / sore throat / pneumonia / disease / seasonal influenza / influenza A / nasal congestion / surrogate influenza / RT-PCR-confirmed influenza A / runny nose / FLU Q-QIV / pandemic influenza / cough / /

MedicalTreatment

vaccination / /

Organization

Food and Drug Administration / New Brunswick Department of Public Health / Biological Products Advisory Committee / DEPARTMENT OF HEALTH / /

Person

Theresa Finn Marion / Lien Lin Douglas Pratt Kirk Prutzman Wellington / Van Buynder / Carmen Collazo-Custodio Theresa / Andrea James Tsai-Lien Lin / Kati Abraham / Marion Gruber Andrea James / Kirk Prutzman Wellington Sun Elizabeth / Katalin Abraham / Carmen CollazoCustodio / Katalin Abraham Donna Boyce / Michael Schwartz David Vaughn / Michael Schwartz / Barbara Howe Bruce Innis Ping / Mike Michael / Pike Rockville / /

/

Product

H1N1 vaccine / Virus Monovalent Vaccine / H1N1 / H5N1 / influenza vaccine / Pan vaccine / QIV-006 / Pan / /

ProvinceOrState

Quebec / California / /

PublishedMedium

the Mid-Cycle Review / /

SocialTag